Download PDF
Horm Metab Res 2003; 35(9): 527-531
DOI: 10.1055/s-2003-42653
Original Clinical
© Georg Thieme Verlag Stuttgart · New York

Effects of Triiodothyronine and Estrogen Administration on Bone Mass, Mineral Content and Bone Strength in Male Rats

P.  D.  Broulik 1 , J.  Rosenkrancová 2 , P.  Růžička 2 , R.  Sedláček 2
  • 1Third Medical Clinic, First Medical Faculty, Charles University, Prague, Czech Republic
  • 2Faculty of Mechanical Engineering, Department of Mechanics, Prague, Czech Republic
Further Information

Publication History

Received 6 January 2003

Accepted after second Revision 14 May 2003

Publication Date:
30 September 2003 (online)

Also available at
    Permissions and Reprints

Abstract

Experimental hyperthyroidism had a negative effect on bone mineral density, but did not significantly alter mechanical properties of femur and femoral bone thickness. Estradiol at a dose used in humans for the treatment of osteoporosis decreased seminal vesicle weight and concentration of testosterone but increased bone density in male rats compared to intact animals. In these rats, the mechanical analysis revealed an increased mechanical femur strength higher than the increase in bone density and femoral cortical thickness. When hyperthyroid male rats with low bone density were treated with estradiol in spite of a low plasma testosterone, the changes in bone density resulting from hyperthyroidism were entirely prevented. Estrogens protect the male skeleton against resorbing action of T3. Treatment with estradiol in male rats with hyperthyroidism did not increase mechanical bone strength or femoral cortical thickness as it did with estradiol administration alone. Our results suggest that exogenously administered estrogens may have therapeutic value in preventing bone loss accompanying triiodothyronine administration, even in male rats with a low testosterone levels. At the concentration studied, estradiol increased in spite of low plasma testosterone, bone mineral density, mechanical strength of femur, and femoral cortical thickness.

Key words

Hyperthyroidism - Bone Mineral Density - Mechanical Strength - Estradiol - Male Rats

References

  • 1 Mosekilde L, Eriksen E F, Charles P. Effects of thyroid hormones on bone and mineral metabolism.  Endocrinol Metab Clin North Am. 1990;  19 35-63
    PubMedSearch in Google Scholar
  • 2 Broulik P D, Steˇpán J. Bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline. excretion in thyrotoxicosis.  Endocrinologia Exp. 1985;  19 165-169
    PubMedSearch in Google Scholar
  • 3 Pantazi H, Papapetrou P D. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.  J Clin Endocrinol Metab. 2000;  85 1099-1106
    CrossrefPubMedSearch in Google Scholar
  • 4 di Pippo V A, Lindsay R, Powers C A. Estradiol and tamoxifen interactions with thyroid hormone in the ovariectomized, thyroidectomized rat.  Endocrinology. 1995;  136 1020-1033
    CrossrefPubMedSearch in Google Scholar
  • 5 Orwell E S, Nelson H D. Does estrogen adequately protect postmenopausal women against osteoporosis: An iconoclastic perspective.  J Clin Endocrinol Metab. 1999;  84 1872-1874
    CrossrefPubMedSearch in Google Scholar
  • 6 Gomez J M, Gomez N, Fiter J, Soler J. Effects of long term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement.  Horm Metab Res. 2000;  32 66-70
    Thieme ConnectPubMedSearch in Google Scholar
  • 7 Seeman E. Pathogenesis of bone fragility in women and men.  Lancet. 2002;  359 1841-1850
    CrossrefPubMedSearch in Google Scholar
  • 8 Fitts J M, Klein R M, Powers C A. Estrogen and tamoxifen interplay with T3 in male rats: pharmacologically distinct classes of estrogen responses affecting growth, bone, and lipid metabolism and their relation to serum GH and IGF 1.  Endocrinology. 2001;  142 4223-4235
    CrossrefPubMedSearch in Google Scholar
  • 9 Kalu D N, Hardin R R, Cockerham R. Evaluation of the pathogenesis of skeletal changes in ovariectomized rats.  Endocrinology. 1994;  115 507-511
    PubMedSearch in Google Scholar
  • 10 Gitelman H J. An improved automated procedure for the determination of calcium in biological specimens.  Anal Biochem. 1967;  18 521-531
    CrossrefPubMedSearch in Google Scholar
  • 11 Kraml J. A semiautomated determination of phospholipids.  Clin Chim Acta. 1966;  13 442- 448
    CrossrefPubMedSearch in Google Scholar
  • 12 Beall P T, Misra L K, Young R L, Spjut H J, Evans H J, Le Blame A. Clomiphene protects against osteoporosis in the mature ovariectomized rat.  Calcif Tissue Int. 1984;  36 123-125
    PubMedSearch in Google Scholar
  • 13 Vanderschueren D E, Vautterck A MH, Suiker W J, Wisser L PC, Schot R, Bouillon R. Bone and mineral metabolism in aged male rats. Short and long term effects of androgen deficiency.  Endocrinology. 1992;  130 2906-2916
    CrossrefPubMedSearch in Google Scholar
  • 14 Turner C H, Burr D B. Basic Biomechanical measurements of bone: A tutorial.  Bone. 1993;  14 595-608
    CrossrefPubMedSearch in Google Scholar
  • 15 Růžička R, Michálek J, Rosenkrancová J, Sedláček R. Cross section parameters acquisition from digital images. Prague; Proc. of workshop 2002, Prague CTU 2002 B: 910-911
    Search in Google Scholar
  • 16 Duncan D. Multiple range and multiple F test.  Biometrics. 1955;  11 1-4
    PubMedSearch in Google Scholar
  • 17 Compston J E. Sex steroids and bone.  Physiol Rev. 2001;  81 419-447
    CrossrefPubMedSearch in Google Scholar
  • 18 Hofbauer L C, Khosla S, Dunstan C R, Lacey D L, Spelsperg T C, Riggs B L. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells.  Endocrinology. 1999;  140 4367-4370
    CrossrefPubMedSearch in Google Scholar
  • 19 Khosla S, Melton L J, Atkinson E J, O'Fallon W A, Klee G G, Riggs B L. Relationship of serum sex steroid levels and bone turnover markers with bone density in men and women a key role for bioavailable estrogen.  J Clin Endocrin Metab. 1998;  83 2266-2274
    CrossrefPubMedSearch in Google Scholar
  • 20 Szulc P, Munoz F, Claustrat B, Garnero P, Marchand F, Duboeuf F, Delmas P D. Bioavailable estradiol may be an important determinant of osteoporosis in men: The MINOS study.  J Clin Endocrinol Metab. 2001;  86 192-199
    CrossrefPubMedSearch in Google Scholar
  • 21 Colvard D S, Eriksen E P, Keeting P E, Wilson E M, Lubahn D B, French F S, Riggs B L, Spelberg T C. Identification of androgen receptors in normal human osteoblast-line cells.  Proc Natl Acad Sci USA. 1989;  86 854-857
    PubMedSearch in Google Scholar
  • 22 Bruch H B, Wolf L, Budde R, Romato G, Schweikert H U. Androstenedione metabolism in cultured human osteoblast-like cells.  J Clin Endocrinol Metab. 1992;  75 101-105
    CrossrefPubMedSearch in Google Scholar
  • 23 Morishima A, Grumbach M M, Simpson E R, Fischer C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens.  J Clin Endocrinol Metab. 1995;  80 3689-3698
    CrossrefPubMedSearch in Google Scholar
  • 24 Lubahn D B, Mayer J S, Golding T S, Couse J F, Korach K S, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.  Proc natl Acad Sci USA. 1993;  90 11 162-11 166
    PubMedSearch in Google Scholar
  • 25 Smith E, Boyd J, Frank G R, Takahashi H, Cohem R M, Specker B, Williams T C, Lubahn D B, Korach K S. Estrogen resistance caused by a mutation in the estrogen-receptor gene in man.  N Engl J med. 1994;  331 1056-1061
    CrossrefPubMedSearch in Google Scholar
  • 26 Vanderschueren D E, van Herck E, Nijs J, Ederveen A GH, de Coster R, Bouillon R. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density In growing male rats.  Endocrinology. 1997;  138 2301-2307
    CrossrefPubMedSearch in Google Scholar

Prof. Dr. P. D. Broulik, M.D. 

3rd Internal Clinic · Medical School

U nemocnice 1 · 12808 Prague 2 · Czech Republic ·

Email: pbrou@lfl.cuni.cz